| Update on Tyrosine Kinase Inhibitors (TKI) in Metastatic Renal Cell Carcinoma - Cancer Network |
|
|
Cancer Network A retrospective study of metastatic renal cell carcinoma (mRCC) patients published in the journal Cancer found that patients treated with tyrosine kinase inhibitors (TKIs) had better overall survival and |